title: Recall inflammatory skin reaction after use of pegylated liposomal doxorubicin in site of previous drug extravasation.
authors.affiliation: Medical Oncology Department, University of Turin, San Luigi di Orbassano Hospital, Gonzole Region 10, 10043 Orbassano, Turin, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: Saini
authors.forename: Alfredo
authors.initials: A
authors.lastname: Berruti
authors.forename: Paola
authors.initials: P
authors.lastname: Sperone
authors.forename: Raffaella
authors.initials: R
authors.lastname: Bitossi
authors.forename: Marco
authors.initials: M
authors.lastname: Tampellini
authors.forename: Luigi
authors.initials: L
authors.lastname: Dogliotti
authors.forename: Gabriella
authors.initials: G
authors.lastname: Gorzegno
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D004317:Doxorubicin / Q000009:adverse effects / Q000031:analogs & derivatives*; D003875:Drug Eruptions / Q000209:etiology*; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000150:complications*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D011092:Polyethylene Glycols / Q000009:adverse effects*; D013997:Time Factors
chemical_list: D000970:Antineoplastic Agents; C506643:liposomal doxorubicin; D011092:Polyethylene Glycols; D004317:Doxorubicin